Genetic fusions of heat-labile toxoid (LT) and heat-stable toxin b (STb) of porcine enterotoxigenic Escherichia coli elicit protective anti-LT and anti-STb antibodies

Clinical and Vaccine Immunology

Volumn 17, Issue 8, 2010, Pages 1223-1231

  Zhang, Weiping ^a   Francis, David H ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; HEAT LABILE TOXOID; HEAT STABLE TOXIN B; HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ANTITOXIN; BACTERIAL TOXIN; BACTERIUM ANTIBODY; ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI VACCINE; HEAT STABLE TOXIN (E COLI); HEAT-LABILE ENTEROTOXIN, E COLI; TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DIARRHEA; ESCHERICHIA COLI; GENE FUSION; GENETIC CODE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PIGLET; PRIORITY JOURNAL; RABBIT; SWINE; THERMOSTABILITY; ANIMAL; BLOOD; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; IMMUNOLOGY; SWINE DISEASES; VETERINARY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITOXINS; BACTERIAL TOXINS; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; RABBITS; RECOMBINANT FUSION PROTEINS; SWINE; SWINE DISEASES; TOXOIDS;

EID: 77955291290     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00095-10     Document Type: Article

References (38)

1. Alexander, T. L. 1994. Neonatal diarrhoea in pigs, p. 151-170. In C. L. Gyles (ed.), Escherichia coli in domestic animals and humans. CAB International, Oxon, United Kingdom.
2. Ausubel, F. M., R. Brent, R. K. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1999. Short protocols in molecular biology, 4th ed. John Wiley & Sons, Inc. New York, NY.
3. Batisson, I., M. Der Vartanian, B. Gaillard-Martinie, and M. Contrepois. 2000. Full capacity of recombinant Escherichia coli heat-stable enterotoxin fusion proteins for extracellular secretion, antigenicity, disulfide bond formation, and activity. Infect. Immun. 68:4064-4074.
4. Berberov, E. M., Y. Zhou, D. H. Francis, M. A. Scott, S. D. Kachman, and R. A. Moxley. 2004. Relative importance of heat labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins. Infect. Immun. 72:3914-3924.
5. Casey, T. A., C. J. Herring, R. A. Schneider, B. T. Bosworth, and S. C. Whipp. 1998. Expression of heat-stable enterotoxin STb by adherent Escherichia coli is not sufficient to cause severe diarrhea in neonatal pigs. Infect. Immun. 66:1270-1272.
6. Cheng, E., L. Cardenas-Freytag, and J. D. Clements. 1999. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT). Vaccine 18:38-49. (Pubitemid 29432136)
7. Choi, A. H. C., K. Smiley, M. Basu, M. M. McNeal, M. Shao, J. A. Bean, J. D. Clements, R. R. Stout, and R. L. Ward. 2007. Protection of mice against rotavirus challenge following intradermal DNA immunization by biojector needle-free injection. Vaccine 25:3215-3218.
8. Clements, J. D. 1990. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heatstable enterotoxins. Infect. Immun. 58:1159-1166.
9. Dubreuil, J. D., A. Letellier, and J. Harel. 1996. A recombinant Escherichia coli heat-stable enterotoxin b (STb) fusion protein eliciting neutralizing antibodies. FEMS Immunol. Med. Microbiol. 13:317-323.
10. Erume, J., E. M. Berberov, S. D. Kachman, M. A. Scott, Y. Zhou, D. H. Francis, and R. A. Moxley. 2008. Comparison of the contributions of heatlabile enterotoxins and heat-stable enterotoxins b to the virulence of enterotoxigenic Escherichia coli in F4ac receptor-positive young pigs. Infect. Immun. 76:3141-3149.
11. Francis, D. H., and J. A. Willgohs. 1991. A live avirulent Escherichia coli vaccine for K88+ enterotoxigenic colibacillosis in weaned pigs. Am. J. Vet. Res. 52:1051-1055.
12. Frantz, J. C., and D. C. Robertson. 1981. Immunological properties of Escherichia coli heat-stable enterotoxins: development of a radioimmunoassay specific for heat-stable enterotoxins with suckling mouse activity. Infect. Immun. 33:193-198.
13. Giannella, R. A., K. W. Drake, and M. Luttrell. 1981. Development of a radioimmunoassay for Escherichia coli heat-stable enterotoxin: comparison with the suckling mouse bioassay. Infect. Immun. 33:186-192.
14. Grange, P. A., L. A. Parrish, and A. K. Erickson. 2006. Expression of putative Escherichia coli heat-labile enterotoxin (LT) receptors on intestinal brush borders from pigs of different ages. Vet. Res. Commun. 30:57-71.
15. Harvey, R. B., R. C. Anderson, K. J. Genovese, T. R. Callaway, and D. J. Nisbet. 2005. Use of competitive exclusion to control enterotoxigenic strains of Escherichia coli in weaned pigs. J. Anim. Sci. 83:44-47.
16. Kauffman, P. E. 1981. Production and evaluation of antibody to the heat-stable enterotoxin from a human strain of enterotoxigenic Escherichia coli. Appl. Environ. Microbiol. 42:611-614.
17. Lapa, J. A., S. A. Sincock, M. Ananthakrishnan, C. K. Porter, F. J. Cassels, C. Brinkley. E. R. Hall, J. Hamont, J. D. Gramling, C. M. Carpenter, S. Baqar, and D. R. Tribble. 2008. Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G. Clin. Vaccine Immunol. 15:1222-1228.
18. Lemere, C. A., E. T. Spooner, J. F. Leverone, C. Mori, and J. D. Clements. 2002. Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT (R192G) as mucosal adjuvants. Neurobiol. Ageing 23:991-1000.
19. Moon, H. W. 1990. Colonization factor antigens of enterotoxigenic Escherichia coli in animals. Curr. Microb. Immun. 151:147-165.
20. Moon, H. W., and T. O. Bunn. 1993. Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals. Vaccine 11:213-220. (Pubitemid 23031510)
21. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
22. Peterson, J. W., and S. C. Whipp. 1995. Comparison of the mechanisms of action of cholera toxin and heat-stable enterotoxins of Escherichia coli. Infect. Immun. 63:1452-1461.
23. Sanchez, J., B. E. Uhlin, T. Grundstrom, J. Holmgren, and T. R. Hirst. 1986. Immunoactive chimeric St-LT enterotoxins of Escherichia coli generated by in vitro gene fusion. FEBS Lett. 208:194-198.
24. Sanchez, J., A. M. Svennerholm, and J. Holmgren. 1988. Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit. FEBS Lett. 241:110-114.
25. Sears, C. L., and J. B. Kaper. 1996. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60:167-215.
26. + T cells with protection against rotovirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J. Virol. 81:3740-3748.
27. Smith, H. W., and M. A. Linggood. 1971. Observation on the pathogenic properties of the K88, HIY and ENT plasmids of Escherichia coli with particular reference to porcine diarrhea. J. Med. Microbiol. 4:467-485.
28. Svennerholm, A. M., and D. Steele. 2004. Microbial-gut interactions in health and disease. Progress in enteric vaccine development. Best Pract. Res. Clin. Gastroenterol. 18:421-445.
29. Svensmark, B., S. E. Jorsal, K. Nielsen, and P. Willeberg. 1989. Epidemiological studies of piglet diarrhoea in intensively managed Danish sow herds. I. Pre-weaning diarrhoea. Acta Vet. Scand. 30:43-53.
30. Tumpey, T., M. Renshaw, J. D. Clements, and J. Katz. 2001. Mucosal delivery of inactivated influenza vaccine induces B cell-dependent heterosubtypic cross-protection against lethal A H5N1 virus infection. J. Virol. 75:5141-5150.
31. VanCott, J. L., A. E. Prada, M. M. McNeal, S. C. Stone, M. Basu, B. Juffer, Jr., K. L. Smiley, M. Shao, J. A. Bean, J. D. Clements, A. H.-C. Choi, and R. L. Ward. 2006. Mice developed effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotovirus vaccine candidates. J. Virol. 80:4949-4961.
32. Whipp, S. C. 1987. Protease degradation of Escherichia coli heat-stable, mouse-negative, pig-positive enterotoxins. Infect. Immun. 55:2057-2060.
33. WHO. 2006. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Wkly. Epidemiol. Rec. 81:97-104.
34. Wilson, M. R., and D. H. Francis. 1986. Fimbriae and enterotoxins associated with Escherichia coli serogroups isolated from pigs with colibacillosis. Am. J. Vet. Res. 47:213-217.
35. Zhang, W., E. Berberov, J. Freeling, D. He, R. A. Moxley, and D. H. Francis. 2006. Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity study. Infect. Immun. 74:3107-3114.
36. Zhang, W., D. C. Robertson, C. Zhang, W. Bai, M. Zhao, and D. H. Francis. 2008. Escherichia coli constructs expressing human or porcine enterotoxins induce identical diarrhea diseases in a piglet infection model. Appl. Environ. Microbiol. 74:5832-5837.
37. Zhang, W., M. Zhao, L. Ruesch, A. Omot, and D. H. Francis. 2007. Prevalence of virulence genes in Escherichia coli strains recently isolated from young pigs with diarrhea in the US. Vet. Microbiol. 123:145-152.
38. Zhang, W., C. Zhang, D. H. Francis, D. Knudsen, Y. Fang, J. P. Nataro, and D. C. Robertson. 2010. Genetic fusions of LTAB and STa toxoids of porcine enterotoxigenic Escherichia coli (ETEC) elicited neutralizing anti-LT and anti-STa antibodies. Infect. Immun. 78:316-325.